nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis
|
Rubio, Angela |
|
|
86 |
P3 |
p. 151-165 |
artikel |
2 |
A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma
|
Pandya, Gouri |
|
|
86 |
P3 |
p. 682-692 |
artikel |
3 |
Anticancer activity of lactic acid bacteria
|
Garbacz, Katarzyna |
|
|
86 |
P3 |
p. 356-366 |
artikel |
4 |
Anticancer natural products targeting immune checkpoint protein network
|
Chun, Kyung-Soo |
|
|
86 |
P3 |
p. 1008-1032 |
artikel |
5 |
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation
|
Motofei, Ion G. |
|
|
86 |
P3 |
p. 600-615 |
artikel |
6 |
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation
|
Queen, Aarfa |
|
|
86 |
P3 |
p. 899-913 |
artikel |
7 |
Carcinogenic microbiota and its role in colorectal cancer development
|
Karpiński, Tomasz M. |
|
|
86 |
P3 |
p. 420-430 |
artikel |
8 |
Characterizing and exploiting the many roles of aberrant H2B monoubiquitination in cancer pathogenesis
|
Jeusset, Lucile M. |
|
|
86 |
P3 |
p. 782-798 |
artikel |
9 |
Checkpoint: Inspecting the barriers in glioblastoma immunotherapies
|
Preddy, Isabelle |
|
|
86 |
P3 |
p. 473-481 |
artikel |
10 |
Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?
|
Ahmad, Mudassier |
|
|
86 |
P3 |
p. 1175-1185 |
artikel |
11 |
Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis
|
Mughees, Mohd |
|
|
86 |
P3 |
p. 497-512 |
artikel |
12 |
Chemokines in colon cancer progression
|
Jia, Sheng-Nan |
|
|
86 |
P3 |
p. 400-407 |
artikel |
13 |
Chemokines network in bone metastasis: Vital regulators of seeding and soiling
|
Sharma, Gunjan |
|
|
86 |
P3 |
p. 457-472 |
artikel |
14 |
Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance
|
Gonzalez-Molina, Jordi |
|
|
86 |
P3 |
p. 224-236 |
artikel |
15 |
Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
|
Nagaraju, Ganji Purnachandra |
|
|
86 |
P3 |
p. 616-621 |
artikel |
16 |
Cooperation and competition by RNA-binding proteins in cancer
|
Nag, Sharanya |
|
|
86 |
P3 |
p. 286-297 |
artikel |
17 |
Cytotoxic activity of l-lysine alpha-oxidase against leukemia cells
|
Costa, Mariana N. |
|
|
86 |
P3 |
p. 590-599 |
artikel |
18 |
Deregulated transcription factors and poor clinical outcomes in cancer patients
|
Li, Yiwei |
|
|
86 |
P3 |
p. 122-134 |
artikel |
19 |
Deregulated transcription factors in cancer cell metabolisms and reprogramming
|
Kant, Rajni |
|
|
86 |
P3 |
p. 1158-1174 |
artikel |
20 |
Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity
|
Anderson, Trevor S. |
|
|
86 |
P3 |
p. 981-996 |
artikel |
21 |
Dysregulated FOXM1 signaling in the regulation of cancer stem cells
|
Sher, Gulab |
|
|
86 |
P3 |
p. 107-121 |
artikel |
22 |
Editorial Board
|
|
|
|
86 |
P3 |
p. ii |
artikel |
23 |
Epigenetics in hepatocellular carcinoma
|
Nagaraju, Ganji Purnachandra |
|
|
86 |
P3 |
p. 622-632 |
artikel |
24 |
Evolution of small cell lung cancer tumor mutation: from molecular mechanisms to novel viewpoints
|
Guan, Xiaojiao |
|
|
86 |
P3 |
p. 346-355 |
artikel |
25 |
Evolving role of immunotherapy in small cell lung cancer
|
Barrows, Elizabeth D. |
|
|
86 |
P3 |
p. 868-874 |
artikel |
26 |
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
|
Niu, Xing |
|
|
86 |
P3 |
p. 273-285 |
artikel |
27 |
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
|
Peltier, Agathe |
|
|
86 |
P3 |
p. 262-272 |
artikel |
28 |
Focus on organoids: cooperation and interconnection with extracellular vesicles – Is this the future of in vitro modeling?
|
Jurj, Ancuta |
|
|
86 |
P3 |
p. 367-381 |
artikel |
29 |
Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
|
Harkus, Uasim |
|
|
86 |
P3 |
p. 799-815 |
artikel |
30 |
Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy
|
Gaikwad, Shreyas |
|
|
86 |
P3 |
p. 137-150 |
artikel |
31 |
Insights into the role of complement regulatory proteins in HPV mediated cervical carcinogenesis
|
Khan, Asiya |
|
|
86 |
P3 |
p. 583-589 |
artikel |
32 |
Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective
|
Panebianco, Concetta |
|
|
86 |
P3 |
p. 997-1007 |
artikel |
33 |
Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches
|
Shaath, Hibah |
|
|
86 |
P3 |
p. 325-345 |
artikel |
34 |
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
|
Wang, Yi |
|
|
86 |
P3 |
p. 542-565 |
artikel |
35 |
Metabolic reservoir cycles in cancer
|
Zhang, Cissy |
|
|
86 |
P3 |
p. 180-188 |
artikel |
36 |
Microbe-based therapies for colorectal cancer: Advantages and limitations
|
Saeed, Mohd |
|
|
86 |
P3 |
p. 652-665 |
artikel |
37 |
Microbes-mediated synthesis strategies of metal nanoparticles and their potential role in cancer therapeutics
|
Khalil, Ali Talha |
|
|
86 |
P3 |
p. 693-705 |
artikel |
38 |
Microbial cancer therapeutics: A promising approach
|
Diwan, Deepti |
|
|
86 |
P3 |
p. 931-950 |
artikel |
39 |
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
|
Haque, Shafiul |
|
|
86 |
P3 |
p. 666-681 |
artikel |
40 |
Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics
|
Prateeksha, |
|
|
86 |
P3 |
p. 706-731 |
artikel |
41 |
Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy
|
Khan, Faizan Haider |
|
|
86 |
P3 |
p. 732-742 |
artikel |
42 |
Microbiota and gastric cancer
|
Bessède, Emilie |
|
|
86 |
P3 |
p. 11-17 |
artikel |
43 |
Microbiota and lung cancer
|
Goto, Taichiro |
|
|
86 |
P3 |
p. 1-10 |
artikel |
44 |
Microbiota and prostate cancer
|
Rizzo, Alessandro |
|
|
86 |
P3 |
p. 1058-1065 |
artikel |
45 |
Modulation and function of Pumilio proteins in cancer
|
Silva, Isabelle Leticia Zaboroski |
|
|
86 |
P3 |
p. 298-309 |
artikel |
46 |
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
|
Schoutrop, Esther |
|
|
86 |
P3 |
p. 207-223 |
artikel |
47 |
Molecular mechanisms underlying the development of neuroendocrine prostate cancer
|
Liu, Shiqin |
|
|
86 |
P3 |
p. 57-68 |
artikel |
48 |
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
|
Patil, Kalyani |
|
|
86 |
P3 |
p. 382-399 |
artikel |
49 |
Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer
|
Zeng, Yongji |
|
|
86 |
P3 |
p. 566-582 |
artikel |
50 |
Multifaceted role of chemokines in solid tumors: From biology to therapy
|
Raza, Sana |
|
|
86 |
P3 |
p. 1105-1121 |
artikel |
51 |
Nanotherapeutics for immune network modulation in tumor microenvironments
|
Lee, Jaiwoo |
|
|
86 |
P3 |
p. 1066-1087 |
artikel |
52 |
Necroptosis pathways in tumorigenesis
|
Zhang, Tao |
|
|
86 |
P3 |
p. 32-40 |
artikel |
53 |
Non-coding genome in small cell lung cancer between theoretical view and clinical applications
|
Yin, Xiaomeng |
|
|
86 |
P3 |
p. 237-250 |
artikel |
54 |
Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme
|
Kazemi Shariat Panahi, Hamed |
|
|
86 |
P3 |
p. 1122-1142 |
artikel |
55 |
Optimal timing of PD-1 blockade in combination with oncolytic virus therapy
|
Nguyen, Hong-My |
|
|
86 |
P3 |
p. 971-980 |
artikel |
56 |
Pivotal role of PD-1/PD-L1 immune checkpoints in immune escape and cancer progression: Their interplay with platelets and FOXP3+Tregs related molecules, clinical implications and combinational potential with phytochemicals
|
Lee, Dae Young |
|
|
86 |
P3 |
p. 1033-1057 |
artikel |
57 |
Promalignant effects of antiangiogenics in the tumor microenvironment
|
Peix, Felix |
|
|
86 |
P3 |
p. 199-206 |
artikel |
58 |
Prospects of microbial-engineering for the production of graphene and its derivatives: Application to design nanosystms for cancer theranostics
|
Singh, Rajeev |
|
|
86 |
P3 |
p. 885-898 |
artikel |
59 |
Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells
|
Berg, Tracy J. |
|
|
86 |
P3 |
p. 846-856 |
artikel |
60 |
Recent advances in microbial toxin-related strategies to combat cancer
|
Sharma, Prabodh Chander |
|
|
86 |
P3 |
p. 753-768 |
artikel |
61 |
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways
|
Therachiyil, Lubna |
|
|
86 |
P3 |
p. 1186-1202 |
artikel |
62 |
Resistance to immune checkpoint blockade: Mechanisms, counter-acting approaches, and future directions
|
Haddad, Alexander F. |
|
|
86 |
P3 |
p. 532-541 |
artikel |
63 |
Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications
|
Maurya, Shailendra Kumar |
|
|
86 |
P3 |
p. 914-930 |
artikel |
64 |
RNA-binding proteins: Underestimated contributors in tumorigenesis
|
Zhao, Y. |
|
|
86 |
P3 |
p. 431-444 |
artikel |
65 |
Roles of RNA-binding proteins in immune diseases and cancer
|
Hashimoto, Shigeru |
|
|
86 |
P3 |
p. 310-324 |
artikel |
66 |
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
|
Chibaya, Loretah |
|
|
86 |
P3 |
p. 827-845 |
artikel |
67 |
Sex dimorphism in the tumor microenvironment – From bench to bedside and back
|
He, Fei |
|
|
86 |
P3 |
p. 166-179 |
artikel |
68 |
Small secretory proteins of immune cells can modulate gynecological cancers
|
Kumar, Niranjan |
|
|
86 |
P3 |
p. 513-531 |
artikel |
69 |
Special issue Microbes in Cancer Research in 'Seminar in Cancer Biology' 2021
|
Kalia, Vipin Chandra |
|
|
86 |
P3 |
p. 1102-1104 |
artikel |
70 |
STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges
|
Wong, Grace L. |
|
|
86 |
P3 |
p. 84-106 |
artikel |
71 |
Surgery-mediated tumor-promoting effects on the immune microenvironment
|
Cheng, Xiang |
|
|
86 |
P3 |
p. 408-419 |
artikel |
72 |
Targeting lactate-related cell cycle activities for cancer therapy
|
Lin, Jia |
|
|
86 |
P3 |
p. 1231-1243 |
artikel |
73 |
Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer
|
Luo, Hao |
|
|
86 |
P3 |
p. 960-970 |
artikel |
74 |
Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy
|
Mir, C. |
|
|
86 |
P3 |
p. 69-83 |
artikel |
75 |
The altered lipidome of hepatocellular carcinoma
|
Tan, Shawn Lu Wen |
|
|
86 |
P3 |
p. 445-456 |
artikel |
76 |
The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer
|
Ramesh-Kumar, Deepthi |
|
|
86 |
P3 |
p. 18-31 |
artikel |
77 |
The impact of VEGF on cancer metastasis and systemic disease
|
Yang, Yunlong |
|
|
86 |
P3 |
p. 251-261 |
artikel |
78 |
The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis
|
Navashenaq, Jamshid Gholizadeh |
|
|
86 |
P3 |
p. 951-959 |
artikel |
79 |
The oral microbiota and its role in carcinogenesis
|
Stasiewicz, Mark |
|
|
86 |
P3 |
p. 633-642 |
artikel |
80 |
The radiobiology of TGFβ
|
Barcellos-Hoff, Mary Helen |
|
|
86 |
P3 |
p. 857-867 |
artikel |
81 |
Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma
|
Yeung, Cherlie Lot Sum |
|
|
86 |
P3 |
p. 1088-1101 |
artikel |
82 |
Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play
|
Erbani, Johanna |
|
|
86 |
P3 |
p. 41-56 |
artikel |
83 |
The role of RNA-binding proteins in the processing of mRNAs produced by carcinogenic papillomaviruses
|
Kajitani, Naoko |
|
|
86 |
P3 |
p. 482-496 |
artikel |
84 |
The role of transcription factors in the acquisition of the four latest proposed hallmarks of cancer and corresponding enabling characteristics
|
Morgan, Maria P. |
|
|
86 |
P3 |
p. 1203-1215 |
artikel |
85 |
Tumor glycolysis, an essential sweet tooth of tumor cells
|
Paul, Sumana |
|
|
86 |
P3 |
p. 1216-1230 |
artikel |
86 |
Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
|
Liu, Hanxin |
|
|
86 |
P3 |
p. 769-781 |
artikel |
87 |
Understanding RNA-binding proteins
|
LLeonart, Matilde E. |
|
|
86 |
P3 |
p. 135-136 |
artikel |
88 |
Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers
|
Kashyap, Sheetal |
|
|
86 |
P3 |
p. 643-651 |
artikel |
89 |
Urinary microbiota and bladder cancer: A systematic review and a focus on uropathogens
|
Yacouba, Abdourahamane |
|
|
86 |
P3 |
p. 875-884 |
artikel |
90 |
Vaginal microbiome and cervical cancer
|
Kyrgiou, Maria |
|
|
86 |
P3 |
p. 189-198 |
artikel |
91 |
Vibrational spectroscopy for decoding cancer microbiota interactions: Current evidence and future perspective
|
Liu, Zhenhui |
|
|
86 |
P3 |
p. 743-752 |
artikel |
92 |
Vimentin and cytokeratin: Good alone, bad together
|
Kuburich, Nick A. |
|
|
86 |
P3 |
p. 816-826 |
artikel |
93 |
Virus-inspired strategies for cancer therapy
|
Ma, Xiao Yin |
|
|
86 |
P3 |
p. 1143-1157 |
artikel |